QM · rank #16 · 2026-09-11
EXENS
PARIS · EUR · $3.29B (USD)
The exact numbers the algorithm saw.
| Momentum 12-1 Return from 12 months ago to 1 month ago. | +65.96% |
|---|---|
| ROE TTM Return on equity, trailing 12 months. | +12.7% |
| Profit margin Net profit margin, trailing 12 months. | +6.0% |
| Market cap (USD) Size filter: > $300M required (USD-equivalent). | $3.29B |
| Anchor (recent) Close on 2026-08-12 | $65.50 |
| Anchor (far) Close on 2025-08-12 | $39.47 |
The AI research card
Independent qualitative review of each pick before the order is placed. On the rare day the research service is unavailable, the paper book trades on the quant ranking alone and no card appears here.
Summary
Exosens is a Paris-listed photonics and optoelectronics specialist supplying night-vision image intensifier tubes, thermal cameras, and digital imaging systems primarily to defense and surveillance customers across Europe and North America.
Rationale
The 66% trailing momentum signal is directly reinforced by accelerating fundamentals—15.3% H1 2026 revenue growth, ~33% adjusted EBITDA margins, guidance raised to the upper end, and named contract visibility (BiNOD IDIQ, ACTinBlack 5G tubes) that gives the quality screen durable earnings support rather than pure sentiment.
Material risks
- 1Defense procurement cycle disruption—specifically, a U.S. budget continuing resolution or NDAA cut that delays BiNOD deliveries, which are a material near-term revenue driver and the clearest single-contract concentration risk.
- 2Export control tightening on dual-use night-vision and photonics technology could restrict international sales precisely as EIB-funded capacity expansion comes online, creating a supply-demand mismatch that pressures margins.
AI verdict council
Each pick is reviewed independently by 3 models before any order. 3 of 3 voted to proceed.